Skip to main content
Clinical Trials/NCT01484886
NCT01484886
Completed
Not Applicable

Prospective Randomized Controlled Clinical Trial Comparing a Restrictive Versus Liberal Transfusion Strategy in Neonates and Infants Undergoing Surgery for Congenital Heart Disease

University of Rochester1 site in 1 country162 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Impaired Oxygen Delivery
Sponsor
University of Rochester
Enrollment
162
Locations
1
Primary Endpoint
oxygen utilization derived from the arterio-venous oxygen difference.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

In neonates and infants </= 10 kg following cardiac surgery for congenital heart disease a more restrictive red blood cell (RBC) transfusion strategy will be as effective as, and possibly superior to, a liberal RBC strategy. Allowing lower hemoglobin concentration will not affect the cardiac or pulmonary status of the patient.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
September 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

jill cholette

Assistant Professor of Pediatrics

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • children \</= 6 months of age with congenital cardiac disease undergoing cardiac surgery with cardiopulmonary bypass.

Exclusion Criteria

  • presence of a known bleeding disorder or coagulopathy.
  • age \> 6 months,
  • lack of informed consent.

Outcomes

Primary Outcomes

oxygen utilization derived from the arterio-venous oxygen difference.

Time Frame: 3 days

Arterial and venous oxygen saturations will be measured every four hours x 48-72 hours and will be used to calculate arterio-venous oxygen content differences.

Secondary Outcomes

  • volume of RBC transfused(7 days)

Study Sites (1)

Loading locations...

Similar Trials